(MedPage Today) — Both time-limited therapy and continuous therapy for chronic lymphocytic leukemia (CLL) have potential benefits and drawbacks. The best choice, a joint decision between clinician and patient, should consider the individual patient…
Source link : https://www.medpagetoday.com/spotlight/asco-cll/116385
Author :
Publish date : 2025-07-07 14:51:00
Copyright for syndicated content belongs to the linked Source.
